On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disease in Cape town
- A triple coincidence that leads to HIV-TB-IRIS
- Antiretroviral therapy improves immunity
- Pathological immunity may be restored by ART
- A wide range of IRIS conditions
- Two forms of IRIS associated with tuberculosis
- Paradoxical TB-IRIS
- Clinical manifestations of paradoxical TB-IRIS
- Histopathology of IRIS
- How significant is IRIS?
- Diagnosing IRIS
- Challenges in diagnosing IRIS
- Pathogenesis of TB-IRIS
- IFN-gamma secreting T cells and TB-IRIS (1)
- HIV-TB-IRIS and M. tuberculosis specific T cells
- T cell expansion & contraction in IRIS & non-IRIS
- T cell expansion further investigation
- IFN-gamma secreting T cells and TB-IRIS (2)
- What is the role of cytokines?
- Cytokine and MMP analysis
- Myeloid origin pro-inflammatory cytokines
- Supernatant cytokines of myeloid origin
- Myeloid origin serum pro-inflammatory cytokines
- Multiply elevated cytokines accompany TB-IRIS
- Management of TB-IRIS
- Randomized trial of prednisone vs. placebo
- Primary endpoint
- Secondary endpoints
- C-reactive protein
- Immunological analysis
- Th1 contraction & expansion: corticosteroids
- Interleukin-6
- Interleukin-10
- Interleukin-12p40
- Tumor necrosis factor
- Interferon-gamma
- Interferon gamma inducible protein 10 (CXCL10)
- Further evidence of innate immune involvement
- Suppurative necrosis may accompany TB-IRIS
- A potential role for neutrophils
- Uncharacteristic cavitation in HIV-TB
- MMP genes and endogenous inhibitors
- In vitro secretion of matrix metalloproteinases
- Serum level of matrix metalloproteinases
- Conclusions: MMP in TB-IRIS
- Conclusions: TB-IRIS
- Acknowledgements
Topics Covered
- TB-immune reconstitution inflammatory syndrome (IRIS) is a common complication of combined antitubercular and antiretroviral therapy
- The two forms of IRIS: paradoxical and unmasking
- Lack of a diagnostic test for TB-IRIS
- Expansion of Interferon gamma secreting T cells is associated with TB-IRIS
- Multiple cytokines are elevated in TB-IRIS, many of myeloid origin
- Benefits of adjunctive corticosteroid therapy in TB-IRIS
- Steroid therapy reduces the levels of IL-6, IL-10, IL-12p40, TNF, Interferon-gamma and CXCL-10 in TB-IRIS patients
- Suppurative necrosis may occur in TB-IRIS, implying a role for neutrophils
- Evidence of a prominent role for myeloid cells in the pathogenesis of TB-IRIS
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Wilkinson, R. and Meintjes, G. (2012, April 3). The role of myeloid cells in HIV associated immune reconstitution inflammatory syndrome [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/TAUO6951.Export Citation (RIS)
Publication History
- Published on April 3, 2012
Financial Disclosures
- Prof. Robert Wilkinson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Prof. Graeme Meintjes has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide